Alternative strategies could be offered to children and young adults with advanced acute lymphoblastic leukemia (ALL) identified as being unlikely to respond to the expensive therapy.
Relapse rates dropped to zero after an intensive regimen of autologous hematopoietic stem cell transplant, but improvement is greater with lower baseline disability.